e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The unknown pathophysiological relevance of right ventricular hypertrophy in pulmonary arterial hypertension
Frances S. de Man, M. Louis Handoko, Anton Vonk-Noordegraaf
Source:
Eur Respir J, 53 (4) 1900255; 10.1183/13993003.00255-2019
Journal Issue:
April
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Frances S. de Man, M. Louis Handoko, Anton Vonk-Noordegraaf. The unknown pathophysiological relevance of right ventricular hypertrophy in pulmonary arterial hypertension. Eur Respir J, 53 (4) 1900255; 10.1183/13993003.00255-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Prognostic relevance of right atrial function in pulmonary arterial hypertension
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension
Source: Eur Respir J, 57 (4) 1901192; 10.1183/13993003.01192-2019
Year: 2021
Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights
Year: 2015
Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
Clinical relevance of right ventricular diastolic stiffness in pulmonary hypertension
Source: Eur Respir J 2015; 45: 1603-1612
Year: 2015
Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008
The role of the right ventricle in pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 243-253
Year: 2011
Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Differences of right ventricular diastolic stiffness in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
The right ventricle in pulmonary arterial hypertension
Source: Eur Respir Rev 2014; 23: 476-487
Year: 2014
Right ventricular diastolic stiffness in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017
Year: 2018
Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 49 (6) 1601419; 10.1183/13993003.01419-2016
Year: 2017
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 224-232
Year: 2013
In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept